Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Financial Statements

Compare
1,032 Followers

Lisata Therapeutics Financial Overview

Lisata Therapeutics's market cap is currently $18.10M. The company's EPS TTM is $-2.399; its P/E ratio is ―; Lisata Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.00M$ 0.00$ 121.37M$ 0.00$ 0.00
Gross Profit$ 1.00M$ -189.00K$ 63.77M$ -55.00K$ -63.00K
Operating Income$ -22.41M$ -25.71M$ -57.60M$ -29.05M$ -19.14M
EBITDA$ -22.23M$ -25.52M$ -115.20M$ -29.00M$ -19.08M
Net Income$ -19.98M$ -20.84M$ -54.23M$ -27.47M$ -8.14M
Balance Sheet
Cash & Short-Term Investments$ 31.25M$ 50.53M$ 69.23M$ 94.97M$ 34.57M
Total Assets$ 35.00M$ 54.69M$ 73.03M$ 97.01M$ 36.00M
Total Debt$ 137.00K$ 305.00K$ 485.00K$ 714.00K$ 624.00K
Net Debt$ -16.07M$ -22.29M$ -31.67M$ -23.93M$ -15.89M
Total Liabilities$ 5.68M$ 6.80M$ 6.71M$ 5.01M$ 3.76M
Stockholders' Equity$ 29.57M$ 48.15M$ 66.58M$ 92.25M$ 32.50M
Cash Flow
Free Cash Flow$ -19.36M$ -20.03M$ -21.45M$ -22.30M$ -8.84M
Operating Cash Flow$ -19.36M$ -20.03M$ -21.17M$ -22.25M$ -8.82M
Investing Cash Flow$ 13.23M$ 10.10M$ 28.91M$ -54.90M$ -7.28M
Financing Cash Flow$ -206.00K$ 385.00K$ -224.00K$ 85.28M$ 18.58M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

Lisata Therapeutics Debt to Assets

Lisata Therapeutics Cash Flow

Lisata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis